] . (2013). First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001). J Infect Dis, 207, 240-247. presented at the 01/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=23125444
. (2015). Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans. J Infect Dis, 211, 518-528. presented at the 02/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25165165